Metabolomics in Otorhinolaryngology.
Otorhinolaryngology
hearing loss
metabolites
metabolomics
precision medicine
sleep apnea
vertigo
Journal
Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
05
2022
accepted:
15
08
2022
entrez:
26
9
2022
pubmed:
27
9
2022
medline:
27
9
2022
Statut:
epublish
Résumé
Otorhinolaryngology (Ear, Nose and Throat-ENT) focuses on inflammatory, immunological, infectious, and neoplastic disorders of the head and neck and on their medical and surgical therapy. The fields of interest of this discipline are the ear, the nose and its paranasal sinuses, the oral cavity, the pharynx, the larynx, and the neck. Besides surgery, there are many other diagnostic aspects of ENT such as audiology and Vestibology, laryngology, phoniatrics, and rhinology. A new advanced technology, named metabolomics, is significantly impacting the field of ENT. All the "omics" sciences, such as genomics, transcriptomics, and proteomics, converge at the level of metabolomics, which is considered the integration of all "omics." Its application will change the way several of ENT disorders are diagnosed and treated. This review highlights the power of metabolomics, including its pitfalls and promise, and several of its most relevant applications in ENT to provide a basic understanding of the metabolites associated with these districts. In particular, the attention has been focused on different heterogeneous diseases, from head and neck cancer to allergic rhinitis, hearing loss, obstructive sleep apnea, noise trauma, sinusitis, and Meniere's disease. In conclusion, metabolomics study indicates a "
Identifiants
pubmed: 36158568
doi: 10.3389/fmolb.2022.934311
pii: 934311
pmc: PMC9493185
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
934311Informations de copyright
Copyright © 2022 Noto, Piras, Atzori, Mussap, Albera, Albera, Casani, Capobianco and Fanos.
Déclaration de conflit d'intérêts
The reviewer AC declared a shared affiliation with the authors AA and RA to the handling editor at the time of review. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neoplasia. 2009 Mar;11(3):269-76, 4p following 269
pubmed: 19242608
Thorax. 2002 Jul;57(7):602-7
pubmed: 12096203
Eur Arch Otorhinolaryngol. 2016 Jan;273(1):51-6
pubmed: 25552243
Cancer Genomics Proteomics. 2013 Sep-Oct;10(5):233-8
pubmed: 24136976
Sci Rep. 2018 Jul 26;8(1):11270
pubmed: 30050090
Science. 1986 Jan 17;231(4735):234-41
pubmed: 2417316
Metabolites. 2021 Sep 09;11(9):
pubmed: 34564431
Auris Nasus Larynx. 2017 Aug;44(4):381-389
pubmed: 27817938
Expert Rev Mol Diagn. 2016 Aug;16(8):869-81
pubmed: 27310602
PLoS One. 2015 Mar 09;10(3):e0119762
pubmed: 25751622
Nat Rev Cancer. 2004 Oct;4(10):781-92
pubmed: 15510159
Minn Med. 2011 Nov;94(11):33-6
pubmed: 22413647
Eur Arch Otorhinolaryngol. 2010 May;267(5):665-71
pubmed: 19760212
Cancer Cell. 2004 Apr;5(4):311-6
pubmed: 15093538
Cell Death Dis. 2017 May 11;8(5):e2780
pubmed: 28492547
Asian Pac J Cancer Prev. 2020 Aug 01;21(8):2463-2468
pubmed: 32856879
Environ Sci Pollut Res Int. 2021 Dec;28(48):68539-68550
pubmed: 34275074
Front Immunol. 2022 Jan 05;12:771136
pubmed: 35069544
J Immunol. 2009 Nov 15;183(10):6041-50
pubmed: 19841183
Sci Rep. 2016 Aug 02;6:30958
pubmed: 27480913
Anal Chem. 2020 Jul 7;92(13):8836-8844
pubmed: 32490663
Semin Oncol. 2004 Dec;31(6):744-54
pubmed: 15599852
Allergy. 2019 Nov;74(11):2064-2076
pubmed: 31070805
Biochim Biophys Acta. 2014 Apr;1837(4):408-17
pubmed: 24183692
Semin Nephrol. 2010 Sep;30(5):500-11
pubmed: 21044761
Am J Transplant. 2005 Dec;5(12):2814-20
pubmed: 16302993
Metabolites. 2019 Nov 01;9(11):
pubmed: 31683919
J R Soc Med. 2006 Sep;99(9):448-51
pubmed: 16946387
J Oral Maxillofac Surg. 2004 Sep;62(9):1055-8
pubmed: 15346353
Physiol Rev. 2010 Jan;90(1):47-112
pubmed: 20086074
Anal Chem. 2013 Dec 17;85(24):11732-8
pubmed: 24187941
Biomed Chromatogr. 2020 Mar;34(3):e4739
pubmed: 31692004
Cancer. 2010 Nov 1;116(21):4914-25
pubmed: 20665484
J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:46-52
pubmed: 25284177
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
Int Arch Otorhinolaryngol. 2019 Apr;23(2):218-220
pubmed: 30956708
JAMA. 2011 Aug 10;306(6):613-9
pubmed: 21828324
Proc Natl Acad Sci U S A. 1968 Aug;60(4):1420-7
pubmed: 4299947
Adv Dent Res. 2011 May;23(2):237-46
pubmed: 21490236
Xenobiotica. 1999 Nov;29(11):1181-9
pubmed: 10598751
J Neurosci. 2000 Dec 1;20(23):8750-3
pubmed: 11102482
Circ Res. 2019 Jun 7;124(12):1704-1706
pubmed: 31170038
J Alzheimers Dis. 2015;45(2):349-62
pubmed: 25589730
Front Oncol. 2021 Sep 03;11:698023
pubmed: 34540667
Oxid Med Cell Longev. 2013;2013:972913
pubmed: 23766865
Head Neck. 2007 Jul;29(7):648-54
pubmed: 17274058
Pediatrics. 2012 Sep;130(3):e714-55
pubmed: 22926176
Hear Res. 2007 Apr;226(1-2):92-103
pubmed: 17224251
Nature. 1989 Dec 21-28;342(6252):918-20
pubmed: 2512508
Neuropsychopharmacology. 2013 May;38(6):1060-7
pubmed: 23303071
Sci Rep. 2019 Jun 25;9(1):9273
pubmed: 31239523
Toxicol Sci. 2015 Dec;148(2):531-43
pubmed: 26358001
PLoS One. 2015 Jun 22;10(6):e0130911
pubmed: 26098428
Biomed Pharmacother. 2022 Jan;145:112425
pubmed: 34800782
Int Heart J. 2011;52(5):266-9
pubmed: 22008433
Metabolomics. 2010 Mar;6(1):78-95
pubmed: 20300169
Am J Otolaryngol. 2018 Mar - Apr;39(2):153-156
pubmed: 29248204
J Clin Sleep Med. 2018 Sep 15;14(9):1559-1567
pubmed: 30176961
Am Fam Physician. 2016 Sep 1;94(5):355-60
pubmed: 27583421